The Perpetual 'War' on Drugs Finds New Targets
The U.S. military proudly announced another deadly strike in the Caribbean Sea, claiming to target a vessel engaged in drug trafficking. This latest incident, killing three people, brings the reported death toll from such operations to 133 individuals across at least 38 attacks since September, according to U.S. Southern Command. Defense Secretary Pete Hegseth even suggested these strikes have
made "top cartel drug-traffickers" cease operations indefinitely, a claim conspicuously devoid of corroborating evidence. This militarized approach, framed as an "armed conflict" against cartels, echoes historical precedents where military might is deployed under the guise of an intractable social problem. Consider the 2003 invasion of Iraq, justified by fabricated intelligence about WMDs, or the
2011 intervention in Libya, a "humanitarian" effort that paved the way for slave markets. The funding mechanisms remain opaque, but the beneficiaries are clear: military contractors and those who profit from a destabilized region, far from the 1% of the population who actually benefit from illicit drug sales according to UNODC data for 2021. While the U.S. maintains a zero-tolerance stance on
alleged drug offenses abroad, its own domestic policy sees pharmaceutical companies lobbying aggressively, with groups like PhRMA spending over $314 million on lobbying in 2023 alone, to flood American communities with highly addictive opioids. The double standard is stark: military force and immediate fatalities for actors in the Global South, while corporate profits and legislative lobbying